• FirefoxInstall the new Firefox »
  •  Dow Up 1.56% Nasdaq Up 0.93%

    CytRx Corporation (CYTR)

    -NasdaqCM
    3.29 Up 0.01(0.30%) 12:20PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:3.28
    Open:3.36
    Bid:3.27 x 3300
    Ask:3.28 x 600
    1y Target Est:10.00
    Beta:1.26
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:3.25 - 3.37
    52wk Range:2.08 - 5.46
    Volume:337,690
    Avg Vol (3m):1,294,770
    Market Cap:183.33M
    P/E (ttm):N/A
    EPS (ttm):-0.55
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTR

    Comparison

    Symbol% ChgMkt Cap
    CYTRUp 0.30%183.33M
    LLYUp 0.52%78.44B
    NVSUp 0.84%242.84B
    SNYUp 0.44%131.24B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,827.68
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.98
    Quarterly EPS Est (Mar-15) :-0.24
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate is aldoxorubicin, which is in Phase III clinical trial as a therapy for patients with soft tissue sar... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback